What We’re Reading: Sanofi, GSK Begin Vaccine Trial; Steroids Effective in Treating COVID-19; ALS Treatment Breakthrough
Sanofi and GSK begin human trials for their COVID-19 vaccine; steroids prove effective in severe COVID-19 cases; a drug combination poses a breakthrough in ALS treatment.
Sanofi, GSK Begin Human COVID-19 Vaccine Trials
Drug makers Sanofi and GlaxoSmithKline (GSK) announced they have started a clinical trial of their protein-based coronavirus disease 2019 (COVID-19) vaccine candidate, Reuters
Study Results Find Steroids Reduce Mortality in Severe COVID-19 Cases
Results from 3 studies show inexpensive and widely available steroids are the most effective treatment for serious COVID-19 cases found to date, NPR
Experimental Drug Combination Slows ALS Progression
Results from a 6-month study of 137 patients show the combination of 2 experimental drugs appears to slow decline in patients with amyotrophic lateral sclerosis (ALS), according to
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Rural-Urban Disparities in Colorectal Cancer Screening Persist
September 21st 2025
- AML Survival After 3 Years in Remission Comparable With General Population
September 20th 2025
- AHA Launches New Initiative to Help Patients With Heart Failure
September 20th 2025
- CSU More Burdensome in Female Patients, Especially in Midlife
September 20th 2025
- Pirtobrutinib Shows Clinically Meaningful PFS Improvement in Frontline CLL
September 19th 2025